TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/29/24 18:43 | 8/27/24 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | D | S | -8 | 1.35 | 0 | -6 | -1 | 759 | D | |||||||||||||||
2/5/24 20:50 | 2/2/24 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | D | S | -87 | 1.37 | 0 | -64 | -8 | 745 | D | |||||||||||||||
8/30/23 16:21 | 8/28/23 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | D | S | -11 | 1.26 | 0 | -9 | -1 | 789 | D | |||||||||||||||
2/6/23 16:15 | 2/3/23 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | S | -22 | 1.81 | 0 | -12 | -2 | 798 | D | ||||||||||||||
12/29/21 18:26 | 12/27/21 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | S.d | -117 | 14.58 | 0 | -8 | -5 | 144 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |